United Theranostics has secured $15 million in funding from Old National Bank to expand its network of radiopharmaceutical therapy clinics for cancer treatment.
The company plans to establish up to eight new centers across the U.S. during the next year. The new clinics will be modeled after United Theranostics' founding site in Glen Burnie, MD, and its most recently opened facility in Princeton, NJ, it said.
United Theranostics offers patients-approved radiopharmaceutical therapies and clinical trials for new radiopharmaceutical drugs under investigation. The company was founded by Michael Morris, MD, Babak Saboury, MD, and Eliot Siegel, MD. In addition, Munir Ghesani, MD, recently joined as chief medical officer and is head of the company’s site in Princeton, NJ, according to the firm.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
